Can AI fix what's broken inside pharma — or is it too high-stakes and too guarded to let AI in? Jonathan Green talks with pharmaceutical expert Wendy Rockwell about the realities of bringing AI into one of the most regulated, security-conscious industries on earth: million-dollar legacy systems, painfully long buying cycles, and the trust problem when AI gives you two different answers to the same question.

Key Takeaways: • Pharma is high-stakes — a wrong answer isn't an inconvenience, it's a risk • Legacy systems cost millions and fragment across regions, making AI adoption hard • AI's inconsistency (same question, different answers) is a real blocker in regulated work • The industry is extremely guarded — security and internet restrictions slow everything • Long buying cycles mean AI has to prove itself before it gets in the door

Notable Quotes: "You can ask the same question twice and get two different answers." — Wendy Rockwell "We're really, really, really guarded." — Wendy Rockwell

Connect with Wendy Rockwell: LinkedIn: https://www.linkedin.com/in/wendy-rockwellmba

Enjoyed this? Follow The Artificial Intelligence Podcast and share it with someone in healthcare or pharma.

Connect with Jonathan Green

 

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Jonathan Green : Artificial Intelligence Expert and Author of ChatGPT Profits. Innehållet i podden är skapat av Jonathan Green : Artificial Intelligence Expert and Author of ChatGPT Profits och inte av, eller tillsammans med, Poddtoppen.